These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 2935320

  • 21. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM.
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [Abstract] [Full Text] [Related]

  • 22. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
    Trinh KA, Nguyen VK, Arnold K, Vo VC, Nguyen NB, Kim T, Ladinsky J.
    Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
    [Abstract] [Full Text] [Related]

  • 23. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T, Youngchaiyudha S, Rungpitarangsri V, Trishnananda M, Ruksakul T, Charnond L, Boonamrung S.
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
    [Abstract] [Full Text] [Related]

  • 24. Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma.
    Tin F, Nyunt Hlaing, Lim MA, Win S, Lasserre R.
    Trans R Soc Trop Med Hyg; 1987 Dec; 81(6):910-2. PubMed ID: 3332509
    [Abstract] [Full Text] [Related]

  • 25. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN.
    Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837
    [Abstract] [Full Text] [Related]

  • 26. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP, Wetsteyn JC, Meuwissen JH.
    Trop Geogr Med; 1982 Oct 15; 34(3):263-5. PubMed ID: 6758246
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
    Thimasarn K, Pinichpongse S, Malikul S, Rooney W, Tansophalaks S.
    Southeast Asian J Trop Med Public Health; 1990 Sep 15; 21(3):404-11. PubMed ID: 2075482
    [Abstract] [Full Text] [Related]

  • 29. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
    Randriamanjaka JR, Le Bras J, Charmot G, Coulaud JP.
    Bull Soc Pathol Exot Filiales; 1989 Sep 15; 82(3):381-4. PubMed ID: 2670291
    [Abstract] [Full Text] [Related]

  • 30. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon, Tan Puay Eng.
    Med J Malaysia; 1983 Sep 15; 38(3):217-23. PubMed ID: 6369092
    [No Abstract] [Full Text] [Related]

  • 31. Chloroquine-resistant falciparum malaria from East Africa.
    Bhattacharya DN, Hall AP.
    J Trop Med Hyg; 1986 Dec 15; 89(6):291-4. PubMed ID: 3543385
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
    Dinis DV, Schapira A.
    Bull Soc Pathol Exot; 1990 Dec 15; 83(4):521-7; discussion 528. PubMed ID: 2286005
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Malaria in Switzerland].
    Fernex M.
    Schweiz Med Wochenschr; 1988 Dec 10; 118(49):1838-43. PubMed ID: 3064291
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
    Marquiño W, Ylquimiche L, Hermenegildo Y, Palacios AM, Falconí E, Cabezas C, Arróspide N, Gutierrez S, Ruebush TK.
    Am J Trop Med Hyg; 2005 May 10; 72(5):568-72. PubMed ID: 15891131
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.